Small Molecule Outsourcing: Getting Timelines, Tech Transfer And Analytics Right

Outsourcing small molecule drug development and manufacturing remains complex—but staying on track with timelines is still critical. Success depends on seamless technology transfers and robust analytical strategies.

In this session, industry experts will share best practices for streamlining processes between sponsors and CDMOs. Attendees will walk away with actionable insights into aligning analytical methods and quality standards to accelerate small molecule production and reduce risk across the development lifecycle.